Yesterday, Feb. 16, 2016, 66 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $5.44 to $6,044,120.00.

Highlighted Stocks Traded by Insiders:

Boston Scientific (BSX) - FREE Research Report

Dockendorff Charles J, who is Director at Boston Scientific, bought 30,000 shares at $16.49 on Feb. 16, 2016. Following this transaction, the Director owned 41,598 shares meaning that the stake was boosted by 258.67% with the 30,000-share transaction.

The shares most recently traded at $17.22, up $0.73, or 4.24% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares bought: 11,700
  • 4-Week # shares sold: 6,216
  • 12-Week # shares bought: 11,700
  • 12-Week # shares sold: 83,723
  • 24-Week # shares bought: 11,700
  • 24-Week # shares sold: 275,502

The average volume for Boston Scientific has been 10.0 million shares per day over the past 30 days. Boston Scientific has a market cap of $22.4 billion and is part of the health care sector and health services industry. Shares are down 6.94% year-to-date as of the close of trading on Tuesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Currently, there are 13 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings

rates Boston Scientific as a

hold

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full

Boston Scientific Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Pros Holdings (PRO) - FREE Research Report

Crump Daniel Blair, who is Chief Operating Officer at Pros Holdings, bought 10,000 shares at $9.48 on Feb. 16, 2016. Following this transaction, the Chief Operating Officer owned 45,840 shares meaning that the stake was boosted by 27.9% with the 10,000-share transaction.

The shares most recently traded at $11.50, up $2.02, or 17.52% since the insider transaction. Historical insider transactions for Pros Holdings go as follows:

  • 4-Week # shares bought: 3,500
  • 4-Week # shares sold: 15,000
  • 12-Week # shares bought: 3,500
  • 12-Week # shares sold: 15,000
  • 24-Week # shares bought: 3,500
  • 24-Week # shares sold: 15,000

The average volume for Pros Holdings has been 273,400 shares per day over the past 30 days. Pros Holdings has a market cap of $301.1 million and is part of the technology sector and computer software & services industry. Shares are down 53.73% year-to-date as of the close of trading on Tuesday.

PROS Holdings, Inc. provides big data software applications worldwide. Currently, there are 4 analysts who rate Pros Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRO - FREE

TheStreet Quant Ratings

rates Pros Holdings as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full

Pros Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Universal (UVV) - FREE Research Report

Moore Eddie N Jr, who is Director at Universal, sold 1,100 shares at $54.28 on Feb. 16, 2016. Following this transaction, the Director owned 21,096 shares meaning that the stake was reduced by 4.96% with the 1,100-share transaction.

The shares most recently traded at $54.71, up $0.43, or 0.79% since the insider transaction. Historical insider transactions for Universal go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 8,177
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 10,494
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 33,183

The average volume for Universal has been 232,800 shares per day over the past 30 days. Universal has a market cap of $1.2 billion and is part of the consumer goods sector and tobacco industry. Shares are down 3.58% year-to-date as of the close of trading on Tuesday.

Universal Corporation operates as a leaf tobacco merchant and processor worldwide. It engages in procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products. The stock currently has a dividend yield of 3.96%. The company has a P/E ratio of 14.0. Currently, there are no analysts who rate Universal a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UVV - FREE

TheStreet Quant Ratings

rates Universal as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance and notable return on equity. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Universal Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.